Global pharma tablet coatings market will witness significant growth over the forecast period owing to rising requirement by the pharmaceutical and nutraceutical sectors and increasing investments towards research and development activities.
Home>Industry Reports>Global Pharma Tablet Coatings Market Assessment, Opportunities and Forecast, 2017-2031F
Global pharma tablet coatings market is projected to witness a CAGR of 6.1% during the forecast period 2024-2031, growing from USD 1.01 billion in 2023 to USD 1.62 billion in 2031F. The growth of the market is supported by the expansion in the pharmaceutical sector and increasing research and development activities.
The rapid growth of the pharmaceutical sector is boosting the global pharma tablet coatings market size. The growth can be attributed to the increasing prevalence of various diseases and disorders and exponential rise in population in various regions across the globe. For instance, Invest India estimated that the pharmaceutical industry in the country is expected to reach USD 130 billion by 2030. Moreover, the increasing emphasis on the quality of pharmaceutical products manufacturing and rising adoption of generic drugs provide lucrative growth opportunities to the market, boosting the requirement for pharma tablet coatings. The increase in stringency by regulatory bodies regarding different excipients and drugs further bolstered the market expansion.
The rising investments by key players in the market to produce equipment that supports the delivery of viable pharma tablet coatings cost-efficient and timely are further propelling the global pharma tablet coatings market growth. Additionally, the rising popularity of biosimilars owing to their cost-effective nature, which increases the accessibility to various treatments and improves the quality of life of the patients, is supporting the expansion of the market for tablet coatings. For instance, 2022 Biosimilar Trends Report by Amgen Biosimilars estimates that for the biosimilars launched in the past three years, in the therapeutic areas, average share was 75%. Biosimilars mimic the active ingredient in the reference biologic and undergo extensive analysis to confirm the presence of similar characteristics to that of the reference biologics. Thus, the biosimilars sector is witnessing significant growth, which in turn is boosting the requirement for pharma tablet coatings and positively influencing the expansion of the market.
The growing popularity of generics can be attributed to their cost-effective nature and the rising awareness of strict regulatory standards these drugs must follow. To receive the stamp of approval from the FDA, the generic drugs must be bioequivalent to their brand-name counterpart. It ensures that two drugs are chemically the same, though the makers of the generic medication are allowed a variation of twenty percent in the active ingredient from the original formula. Even though the wiggle room allowed by the FDA is up to 20%, variations of less than 4% are usually observed. Due to the increasing awareness among the general population about such strict regulatory standards followed by generic medications has boosted confidence in such drugs. For instance, the Association for Accessible Medicines estimates that approximately 90% of the prescriptions dispensed in the United States are of generics. Thus boosting the demand for pharma-coating tablets and supporting the market's growth.
Introducing new process analytical technology (PAT) tools for data acquisition and real-time monitoring for filming coating operations is an emerging global pharma tablet coatings market trend. Various PAT tools include a wide range of techniques, such as microscopic techniques, spectroscopic techniques, and imaging techniques, to monitor the film coating operations. Recently, the successful development of various advanced technologies has aided in enhancing the scalability of the coating operations. For instance, the Raman spectroscopy technology underwent various improvements to make it more user-friendly, achieving a more compact form factor, and enhance the calibration stability. Similarly, a research group at Rutgers University comprehensively evaluated advanced multi-point NIR spatially resolved spectroscopy (SRS) probes. These probes provide rapid and precise measurements. The high efficiency and precision offered by this technology has allowed the inspection of approximately 200,000 tablets per hour. Such developments and advancements will provide lucrative growth opportunities to the market over the forecast period.
The growth of North America pharma tablet coatings market can be attributed to the rapid expansion of pharmaceutical sector in the region, strong presence of various leading market players, and increasing prevalence of several diseases and disorders. The rising investments by the market players based in the region towards the development of novel products and technologies are further aiding the growth of the market in North America.
For instance, in May 2023, Colorcon, headquartered in Pennsylvania, United States, introduced titanium dioxide-free film coating designed to mitigate the challenges associated with moisture-sensitive actives. Colorcon launched an Opadry film coating system that meets the moisture management requirements of pharmaceutical tablets without utilizing titanium dioxide. Through their portfolio of Opadry complete film coating systems, the company provides scope for reducing time-to-market and complexity by providing high-quality products to their customers. They are focused on carefully selecting ingredients that meet the local pharmaceutical regulatory requirements. Such regional developments will provide lucrative growth opportunities for the North American market.
The growth of the segment can be attributed to the increasing prevalence of various diseases and disorders that require sustained and controlled release of drugs, including hypertension, diabetes, and asthma. For instance, the International Diabetes Federation estimated that, in 2021, approximately 10.5% of the adult population, i.e., individuals between the age of 20-79 years had diabetes. Also, by 2045 the number of cases of diabetes will witness an increase of 46% and 1 in 8 adults, about 783 million individuals will be living with diabetes. The increase in prevalence of diabetes will boost the requirement for sustained release pharma tablet costings, augmenting the market's growth.
Additionally, the utilization of sustained-release tablets offers various advantages, including slow drug release in the bloodstream, which allows for maintaining a constant level of medication in the bloodstream and removes the likelihood of burst drug release. Thus, it boosts demand and propels the market expansion.
The expansion of the pharmaceutical sector can be attributed to the exponential growth of the geriatric population, the increase in the prevalence of several diseases, and rising healthcare expenditure in various countries across the globe. Due to the growth, the requirement for pharma tablet coatings is increasing, augmenting the market demand. Additionally, the demand for tablet coatings by the pharmaceutical sector is augmenting as the prevalence of diseases that require tablet formulations as the primary form of treatment rises.
For instance, the rise in the number of cases of arthritis is boosting the demand for global pharma tablet coatings. According to the estimates of the Centers for Disease Control and Prevention, an estimated 53.2 million adults in the United States, approximately 21.2% of the population, have been diagnosed by a doctor to have some form of arthritis in 2023. The increase in the number of cases of arthritis is providing lucrative growth opportunities to the market as various corticosteroid medications are consumed as pills for slowing the joint damage and reducing pain and inflammation. Thus, boosting the requirement for pharma tablet coatings and supporting the expansion of the market.
Future Market Scenario (2024 – 2031F)
According to global pharma tablet coatings market analysis, the increasing emphasis on nanocoating technology will support the expansion of the market in the coming years. The growing utilization of nanotechnology will aid in enhancing the capabilities of the excipients. Nanocoating will aid in improving drug release profiles by enhancing the bioavailability of active pharmaceutical ingredient and controlling the release rate. Furthermore, the utilization of nanocoating technology will support the incorporation of different functional materials including antimicrobial agents, flavoring agents, antioxidants, and polymers, onto the surface of the tablet. The increasing utilization of nanocoating technology will provide various benefits and support the expansion of the market for pharma tablet coatings over the forecast period.
Report Scope
“Pharma Tablet Coatings Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global pharma tablet coatings market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
Report Attribute |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2017-2022 |
Forecast Period |
2024-2031F |
Projected Growth Rate |
CAGR of 6.1% between 2024-2031F |
Revenue Forecast in 2031 |
USD 1.62 billion |
Segments Covered |
Type, Polymer Type, Functionality, End-user |
Regions Covered |
North America, Europe, South America, Asia-Pacific, Middle East and Africa |
Key Companies Profiled |
NEHA LIFE SCIENCES PVT. LTD., UPM Pharmaceuticals, Inc., Evonik Industries, BASF Pharma, Colorcon, EasyCoat, METTLER TOLEDO, Lonza, Qualicaps, SPI Pharma |
Customization Scope |
15% free report customization with purchase |
Pricing and Purchase Options |
Avail the customized purchase options to fulfill your precise research needs |
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In the report, global pharma tablet coatings market has been segmented into the following categories:
Key Players Landscape and Outlook
The increasing investments by the leading pharma tablet coatings market players towards the development of new coating manufacturing facilities will support the global pharma tablet coatings market growth. For instance, Colorcon is investing in the development of a new manufacturing facility in Johor State, Malaysia, through their subsidiary, Colorcon Malaysia. The facility will be producing advanced and high-quality film-coating products to cater to the requirements of nutraceutical and pharmaceutical manufacturers across the region of the Southeast Asia, comprising of New Zealand and Australia. With an investment of approximately USD 50 million, the strategic approach of Colorcon to be located closer to their customers will boost the ability of the company to cater to the expected growth in the region. Thus, increase in such investments over the forecast period will provide lucrative growth opportunities for the market.
Key Players Operating in Global Pharma Tablet Coatings Market are:
Markets and Data report answers the following questions:
If you can't find what you're searching for or have any custom requirements for global pharma tablet coatings market, you may approach our team at info@marketsandata.com
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Voice of Customer
4.1. Market Awareness and Product Information
4.2. Brand Awareness and Loyalty
4.3. Factors Considered in Purchase Decision
4.3.1.Brand Name
4.3.2.Quality
4.3.3.Quantity
4.3.4.Price
4.3.5.Product Specification
4.3.6.Form Specification
4.3.7.Shelf Life
4.3.8.Availability of Product
4.4. Frequency of Purchase
4.5. Medium of Purchase
5. Global Pharma Tablet Coatings Market Outlook, 2017-2031F
5.1. Market Size & Forecast
5.1.1.By Value
5.1.2.By Volume
5.2.1.Sugar Coated
5.2.2.Film Coated
5.2.3.Enteric Coated
5.2.4.Gelatin Coated
5.2.5.Others
5.3. By Polymer Type
5.3.1.Cellulosic
5.3.2.Vinyl
5.3.3.Acrylic
5.3.4.Others
5.4. By Functionality
5.4.1.Delayed-Release
5.4.2.Sustained-Release
5.5. By End-user
5.5.1.Pharmaceutical
5.5.2.Nutraceutical
5.6. By Region
5.6.1.North America
5.6.2.South America
5.6.3.Europe
5.6.4.Asia-Pacific
5.6.5.Middle East and Africa
5.7. By Company Market Share (%), 2023
6. Global Pharma Tablet Coatings Market Outlook, By Region, 2017-2031F
6.1. North America*
6.1.1.Market Size & Forecast
6.1.1.1. By Value
6.1.1.2. By Volume
6.1.2.By Type
6.1.2.1. Sugar Coated
6.1.2.2. Film Coated
6.1.2.3. Enteric Coated
6.1.2.4. Gelatin Coated
6.1.2.5. Others
6.1.3.By Polymer Type
6.1.3.1. Cellulosic
6.1.3.2. Vinyl
6.1.3.3. Acrylic
6.1.3.4. Others
6.1.4.By Functionality
6.1.4.1. Delayed-Release
6.1.4.2. Sustained-Release
6.1.5.By End-user
6.1.5.1. Pharmaceutical
6.1.5.2. Nutraceutical
6.1.6.United States*
6.1.6.1. Market Size & Forecast
6.1.6.1.1. By Value
6.1.6.1.2. By Volume
6.1.6.2. By Type
6.1.6.2.1. Sugar Coated
6.1.6.2.2. Film Coated
6.1.6.2.3. Enteric Coated
6.1.6.2.4. Gelatin Coated
6.1.6.2.5. Others
6.1.6.3. By Polymer Type
6.1.6.3.1. Cellulosic
6.1.6.3.2. Vinyl
6.1.6.3.3. Acrylic
6.1.6.3.4. Others
6.1.6.4. By Functionality
6.1.6.4.1. Delayed-Release
6.1.6.4.2. Sustained-Release
6.1.6.5. By End-user
6.1.6.5.1. Pharmaceutical
6.1.6.5.2. Nutraceutical
6.1.7.Canada
6.1.8.Mexico
*All segments will be provided for all regions and countries covered
6.2. Europe
6.2.1.Germany
6.2.2.France
6.2.3.Italy
6.2.4.United Kingdom
6.2.5.Russia
6.2.6.Netherlands
6.2.7.Spain
6.2.8.Turkey
6.2.9.Poland
6.3. Asia-Pacific
6.3.1.India
6.3.2.China
6.3.3.Japan
6.3.4.Australia
6.3.5.Vietnam
6.3.6.South Korea
6.3.7.Indonesia
6.3.8.Philippines
6.4. South America
6.4.1.Brazil
6.4.2.Argentina
6.5. Middle East and Africa
6.5.1.Saudi Arabia
6.5.2.UAE
6.5.3.South Africa
7. Supply Side Analysis
7.1. Capacity, By Company
7.2. Production, By Company
7.3. Operating Efficiency, By Company
7.4. Key Plant Locations (Up to 25)
8. Market Mapping, 2023
8.1. By Type
8.2. By Polymer Type
8.3. By Functionality
8.4. By End-user
8.5. By Region
9. Macro Environment and Industry Structure
9.1. Supply Demand Analysis
9.2. Import Export Analysis
9.3. Supply Chain Analysis
9.4. PESTEL Analysis
9.4.1.Political Factors
9.4.2.Economic System
9.4.3.Social Implications
9.4.4.Technological Advancements
9.4.5.Environmental Impacts
9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
9.5. Porter’s Five Forces Analysis
9.5.1.Supplier Power
9.5.2.Buyer Power
9.5.3.Substitution Threat
9.5.4.Threat from New Entrant
9.5.5.Competitive Rivalry
10. Market Dynamics
10.1. Growth Drivers
10.2. Growth Inhibitors (Challenges and Restraints)
11. Key Players Landscape
11.1. Competition Matrix of Top Five Market Leaders
11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4. SWOT Analysis (For Five Market Players)
11.5. Patent Analysis (If Applicable)
12. Pricing Analysis
13. Case Studies
14. Key Players Outlook
14.1. NEHA LIFE SCIENCES PVT. LTD.
14.1.1. Company Details
14.1.2. Key Management Personnel
14.1.3. Products & Services
14.1.4. Financials (As reported)
14.1.5. Key Market Focus & Geographical Presence
14.1.6. Recent Developments
14.2. UPM Pharmaceuticals, Inc.
14.3. Evonik Industries
14.4. BASF Pharma
14.5. Colorcon
14.6. EasyCoat
14.7. METTLER TOLEDO
14.8. Lonza
14.9. Qualicaps
14.10. SPI Pharma
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
15. Strategic Recommendations
16. About Us & Disclaimer
List of Figures
Figure 1. Global Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 3. Global Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 4. Global Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 5. Global Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 6. Global Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 7. Global Pharma Packaging Materials Market Share (%), By Region, 2017-2031F
Figure 8. North America Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 10. North America Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 11. North America Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 12. North America Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 13. North America Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 14. North America Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
Figure 15. United States Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 17. United States Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 18. United States Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 19. United States Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 20. United States Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 23. Canada Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 24. Canada Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 25. Canada Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 26. Canada Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 29. Mexico Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 30. Mexico Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 31. Mexico Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 32. Mexico Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 35. Europe Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 36. Europe Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 37. Europe Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 38. Europe Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
Figure 40. Germany Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 42. Germany Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 43. Germany Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 44. Germany Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 45. Germany Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 46. France Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 48. France Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 49. France Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 50. France Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 51. France Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 54. Italy Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 55. Italy Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 56. Italy Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 57. Italy Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 60. United Kingdom Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 61. United Kingdom Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 62. United Kingdom Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 63. United Kingdom Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 66. Russia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 67. Russia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 68. Russia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 69. Russia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 72. Netherlands Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 73. Netherlands Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 74. Netherlands Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 75. Netherlands Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 78. Spain Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 79. Spain Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 80. Spain Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 81. Spain Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 84. Turkey Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 85. Turkey Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 86. Turkey Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 87. Turkey Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 90. Poland Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 91. Poland Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 92. Poland Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 93. Poland Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 94. South America Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 96. South America Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 97. South America Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 98. South America Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 99. South America Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 100. South America Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 103. Brazil Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 104. Brazil Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 105. Brazil Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 106. Brazil Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 109. Argentina Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 110. Argentina Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 111. Argentina Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 112. Argentina Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 115. Asia-Pacific Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 116. Asia-Pacific Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 117. Asia-Pacific Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 118. Asia-Pacific Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
Figure 120. India Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 122. India Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 123. India Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 124. India Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 125. India Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 126. China Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 128. China Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 129. China Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 130. China Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 131. China Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 134. Japan Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 135. Japan Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 136. Japan Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 137. Japan Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 140. Australia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 141. Australia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 142. Australia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 143. Australia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 146. Vietnam Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 147. Vietnam Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 148. Vietnam Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 149. Vietnam Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 152. South Korea Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 153. South Korea Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 154. South Korea Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 155. South Korea Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 158. Indonesia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 159. Indonesia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 160. Indonesia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 161. Indonesia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 164. Philippines Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 165. Philippines Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 166. Philippines Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 167. Philippines Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 170. Middle East & Africa Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 171. Middle East & Africa Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 172. Middle East & Africa Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 173. Middle East & Africa Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Pharma Packaging Materials Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 177. Saudi Arabia Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 178. Saudi Arabia Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 179. Saudi Arabia Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 180. Saudi Arabia Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 183. UAE Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 184. UAE Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 185. UAE Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 186. UAE Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Pharma Packaging Materials Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Pharma Packaging Materials Market, By Volume, In Million Square Feet, 2017-2031F
Figure 189. South Africa Pharma Packaging Materials Market Share (%), By Packaging Type, 2017-2031F
Figure 190. South Africa Pharma Packaging Materials Market Share (%), By Raw Material, 2017-2031F
Figure 191. South Africa Pharma Packaging Materials Market Share (%), By Drug Delivery, 2017-2031F
Figure 192. South Africa Pharma Packaging Materials Market Share (%), By End-user, 2017-2031F
Figure 193. By Packaging Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Raw Material Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Drug Delivery Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Global compression therapy market is anticipated to witness significant growth over the forecast period owing to increasing investments by various companies towards novel product launches and the rise in the number of sports-related injuries.....Read More
Published on
July 2024
4,500
Global liquid biopsy market is projected to experience significant growth over the forecast period owing to increasing preference for non-invasive diagnostic procedures and rising cases of cancer.....Read More
Published on
July 2024
4,500
Global automotive green tire market is expected to experience growth due to rising demand for electric vehicles, rapid trend of personalization, stringent regulations for reducing carbon emissions, and advancement in tire technology.....Read More
Published on
July 2024
4,500
Global automotive bushing market is expected to experience growth due to rise in automotive production, a rapid shift toward electric vehicles, high demand for luxurious vehicles, and an increase in the production of automotive bushing. ....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US